Skip to content

Clinical trials

Scleroderma, Systemic trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Country / region: Italy Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20074
20082
20091
20112
20121
20138
20153
20162
20172
20192
20203
20211
20225
20234
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Unknown status11
Terminated6
Recruiting4
Active, not recruiting3
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim3
Actelion2
ISDIN2
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company2
Lakefront Biotherapeutics NV2
Sanofi2
Università Politecnica delle Marche2
ASST Gaetano Pini-CTO1
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic47
Scleroderma, Diffuse10
Lung Diseases, Interstitial6
Arthritis, Rheumatoid3
Fibrosis2
Hypertension, Pulmonary2
Lupus Erythematosus, Systemic2
Myositis2
Ulcer2
Arrhythmias, Cardiac1

Trials

Showing 51 to 47 of 47. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.